Works matching IS 09024441 AND DT 2024 AND VI 113 AND IP 3
Results: 16
Cytokine expression in pediatric patients with immune thrombocytopenia (ITP) in different phases of disease.
- Published in:
- European Journal of Haematology, 2024, v. 113, n. 3, p. 384, doi. 10.1111/ejh.14262
- By:
- Publication type:
- Article
Childhood autoimmune hemolytic anemia: A scoping review.
- Published in:
- European Journal of Haematology, 2024, v. 113, n. 3, p. 273, doi. 10.1111/ejh.14253
- By:
- Publication type:
- Article
Time‐dependent cost comparison and health economic impact analysis of second‐line interventions for transplant‐ineligible patients with relapsed or refractory diffuse large B cell lymphoma.
- Published in:
- European Journal of Haematology, 2024, v. 113, n. 3, p. 371, doi. 10.1111/ejh.14248
- By:
- Publication type:
- Article
Reviewing the impact of hydroxyurea on DNA methylation and its potential clinical implications in sickle cell disease.
- Published in:
- European Journal of Haematology, 2024, v. 113, n. 3, p. 264, doi. 10.1111/ejh.14247
- By:
- Publication type:
- Article
Differences in the proteome within extracellular vesicles between premalignant and malignant plasma cell disorders.
- Published in:
- European Journal of Haematology, 2024, v. 113, n. 3, p. 351, doi. 10.1111/ejh.14246
- By:
- Publication type:
- Article
Prognosis of pediatric BCP‐ALL with IKZF1 deletions and impact of intensive chemotherapy: Results of SCCLG‐2016 study.
- Published in:
- European Journal of Haematology, 2024, v. 113, n. 3, p. 357, doi. 10.1111/ejh.14245
- By:
- Publication type:
- Article
Plain language summary on "Interim analyses of the multinational real‐world prospective cohort HEM‐POWR study evaluating the effectiveness and safety of damoctocog alfa pegol in patients with hemophilia A".
- Published in:
- European Journal of Haematology, 2024, v. 113, n. 3, p. 387, doi. 10.1111/ejh.14244
- Publication type:
- Article
Pharmacokinetics, pharmacodynamics, and tolerability of an aqueous formulation of rusfertide (PTG‐300), a hepcidin mimetic, in healthy volunteers: A double‐blind first‐in‐human study.
- Published in:
- European Journal of Haematology, 2024, v. 113, n. 3, p. 340, doi. 10.1111/ejh.14243
- By:
- Publication type:
- Article
Soluble MIC‐A, IPI, and response to treatment strongly predict survival in patients with germinal center diffuse large B cell lymphoma.
- Published in:
- European Journal of Haematology, 2024, v. 113, n. 3, p. 321, doi. 10.1111/ejh.14230
- By:
- Publication type:
- Article
Rapid response system for critically ill patients with haematological malignancies: A pre‐ and post‐intervention study.
- Published in:
- European Journal of Haematology, 2024, v. 113, n. 3, p. 330, doi. 10.1111/ejh.14228
- By:
- Publication type:
- Article
A post hoc analysis of PROTECT VIII Kids assessing long‐term efficacy and safety of damoctocog alfa pegol in adolescents with severe haemophilia A.
- Published in:
- European Journal of Haematology, 2024, v. 113, n. 3, p. 386, doi. 10.1111/ejh.14226
- Publication type:
- Article
Isatuximab plus pomalidomide and dexamethasone in patients with relapsed/refractory multiple myeloma in real‐world: The retrospective IMAGE study.
- Published in:
- European Journal of Haematology, 2024, v. 113, n. 3, p. 290, doi. 10.1111/ejh.14225
- By:
- Publication type:
- Article
Effectiveness and safety of belantamab mafodotin in patients with relapsed or refractory multiple myeloma in real‐world setting: The ALFA study.
- Published in:
- European Journal of Haematology, 2024, v. 113, n. 3, p. 310, doi. 10.1111/ejh.14222
- By:
- Publication type:
- Article
A prospective study of posttransplant cyclophosphamide for unrelated donor peripheral blood stem cell transplant with special attention to graft content and the impact of a higher γδ T cell dose.
- Published in:
- European Journal of Haematology, 2024, v. 113, n. 3, p. 283, doi. 10.1111/ejh.14221
- By:
- Publication type:
- Article
Exercise in newly diagnosed patients with multiple myeloma: A randomized controlled trial of effects on physical function, physical activity, lean body mass, bone mineral density, pain, and quality of life.
- Published in:
- European Journal of Haematology, 2024, v. 113, n. 3, p. 298, doi. 10.1111/ejh.14215
- By:
- Publication type:
- Article
Issue Information.
- Published in:
- European Journal of Haematology, 2024, v. 113, n. 3, p. 261, doi. 10.1111/ejh.14002
- Publication type:
- Article